These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Blood Levels to Optimize Antipsychotic Treatment in Clinical Practice: A Joint Consensus Statement of the American Society of Clinical Psychopharmacology and the Therapeutic Drug Monitoring Task Force of the Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie. Schoretsanitis G; Kane JM; Correll CU; Marder SR; Citrome L; Newcomer JW; Robinson DG; Goff DC; Kelly DL; Freudenreich O; Piacentino D; Paulzen M; Conca A; Zernig G; Haen E; Baumann P; Hiemke C; Gründer G; ; Pharmakopsychiatrie TTDMTFOTAFNU J Clin Psychiatry; 2020 May; 81(3):. PubMed ID: 32433836 [TBL] [Abstract][Full Text] [Related]
6. The AGNP-TDM expert group consensus guidelines: therapeutic drug monitoring in psychiatry. Baumann P; Hiemke C; Ulrich S; Eckermann G; Gaertner I; Gerlach M; Kuss HJ; Laux G; Müller-Oerlinghausen B; Rao ML; Riederer P; Zernig G; Pharmacopsychiatry; 2004 Nov; 37(6):243-65. PubMed ID: 15551191 [TBL] [Abstract][Full Text] [Related]
7. Consensus Guideline Based Therapeutic Drug Monitoring (TDM) in Psychiatry and Neurology. Hiemke C Curr Drug Deliv; 2016; 13(3):353-61. PubMed ID: 26511090 [TBL] [Abstract][Full Text] [Related]
8. A Critical Commentary on the 2017 AGNP Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology. de Leon J Pharmacopsychiatry; 2018 Jan; 51(1-02):63-68. PubMed ID: 28922669 [TBL] [Abstract][Full Text] [Related]
9. [Therapeutic drug monitoring in neuropsychopharmacology : Summary of the consensus guidelines 2017 of the TDM task force of the AGNP]. Unterecker S; Hefner G; Baumann P; Gründer G; Bergemann N; Clement HW; Conca A; Deckert J; Domschke K; Eckermann G; Egberts K; Gerlach M; Greiner C; Haen E; Havemann-Reinecke U; Helmer R; Janssen G; Jaquenoud E; Laux G; Messer T; Mössner R; Müller MJ; Paulzen M; Pfuhlmann B; Riederer P; Saria A; Schoppek B; Schoretsanitis G; Schwarz M; Gracia MS; Stegmann B; Steimer W; Stingl JC; Uhr M; Ulrich S; Waschgler R; Zernig G; Zurek G; Hiemke C Nervenarzt; 2019 May; 90(5):463-471. PubMed ID: 30446893 [TBL] [Abstract][Full Text] [Related]
11. French summaries of product characteristics: content in relation to therapeutic monitoring of psychotropic drugs. Rougemont M; Ulrich S; Hiemke C; Corruble E; Baumann P Fundam Clin Pharmacol; 2010 Jun; 24(3):377-84. PubMed ID: 20199581 [TBL] [Abstract][Full Text] [Related]
12. The AGNP-TDM Expert Group Consensus Guidelines: focus on therapeutic monitoring of antidepressants. Baumann P; Ulrich S; Eckermann G; Gerlach M; Kuss HJ; Laux G; Müller-Oerlinghausen B; Rao ML; Riederer P; Zernig G; Hiemke C; Dialogues Clin Neurosci; 2005; 7(3):231-47. PubMed ID: 16156382 [TBL] [Abstract][Full Text] [Related]
13. [Therapeutic drug monitoring in psychiatry. A brief summary of the new consensus paper by the task force on TDM of the AGNP]. Gründer G; Baumann P; Conca A; Zernig G; Hiemke C; Nervenarzt; 2014 Jul; 85(7):847-55. PubMed ID: 24346428 [TBL] [Abstract][Full Text] [Related]
14. Therapeutic drug monitoring in neuropsychopharmacology: does it hold its promises? Hiemke C Eur Arch Psychiatry Clin Neurosci; 2008 Mar; 258 Suppl 1():21-7. PubMed ID: 18344046 [TBL] [Abstract][Full Text] [Related]
15. Consensus guideline for therapeutic drug monitoring in psychiatry (2004): Bibliometric analysis of citations for the period 2004-2011. Schäfer A; Hiemke C; Baumann P Nord J Psychiatry; 2016; 70(3):202-7. PubMed ID: 26399163 [TBL] [Abstract][Full Text] [Related]
16. Therapeutic monitoring of psychotropic drugs: an outline of the AGNP-TDM expert group consensus guideline. Baumann P; Hiemke C; Ulrich S; Gaertner I; Rao ML; Eckermann G; Gerlach M; Kuss HJ; Laux G; Müller-Oerlinghausen B; Riederer P; Zernig G Ther Drug Monit; 2004 Apr; 26(2):167-70. PubMed ID: 15228159 [TBL] [Abstract][Full Text] [Related]
17. Clinical utility of drug measurement and pharmacokinetics: therapeutic drug monitoring in psychiatry. Hiemke C Eur J Clin Pharmacol; 2008 Feb; 64(2):159-66. PubMed ID: 18196227 [TBL] [Abstract][Full Text] [Related]
18. [Therapeutic drug monitoring (TDM) of psychotropic drugs: a consensus guideline of the AGNP-TDM group]. Baumann P; Hiemke C; Ulrich S; Eckermann G; Kuss HL; Laux G; Müller-Oerlingenhausen B; Rao ML; Riederer P; Zernig G; ; Rev Med Suisse; 2006 May; 2(67):1413-8, 1420-2, 1424-6. PubMed ID: 16786958 [TBL] [Abstract][Full Text] [Related]
19. [Therapeutic drug monitoring in child and adolescent psychiatry--practical recommendations]. Gerlach M; Rothenhöfer S; Mehler-Wex C; Fegert JM; Schulz E; Wewetzer C; Warnke A Z Kinder Jugendpsychiatr Psychother; 2006 Jan; 34(1):5-13. PubMed ID: 16485609 [TBL] [Abstract][Full Text] [Related]
20. Therapeutic drug monitoring in psychiatry. Češková E; Šilhán P Cas Lek Cesk; 2023; 162(4):148-151. PubMed ID: 37734940 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]